Abstract The melanocortin‐4 receptor (MC4R) antagonistic peptide TCMCB07 was developed for the treatment of cachexia. The objectives of this study were to examine pharmacokinetics and safety of TCMCB07 administered subcutaneously to healthy dogs. Dogs were treated with high‐ (2.25 mg kg−1) (n = 5) and low‐dose TCMCB07 (0.75 mg kg−1) (n = 5) once daily for 28 days with a 14‐day washout period between groups. Histamine levels, complete blood count, chemistry panel, blood pressure, 24‐hour Holter recording, and pharmacokinetic parameters were monitored in the high‐dose group. Physical examination changes were limited to weight gain and darkening of the coat color. There was no elevation of plasma histamine within 24 hours of injection but ther...
Accumulation of lipofuscin bisretinoids in the retina contributes to pathogenesis of macular degener...
Due to the character of the original source materials and the nature of batch digitization, quality ...
Cimicoxib is a new coxib anti-inflammatory drug for use in the dog. To determine a preclinical dosag...
Combretastatin A4-Phosphate (CA4P) is a vascular disrupting agent revealing promising results in can...
<p>Combretastatin A4-Phosphate (CA4P) is a vascular disrupting agent revealing promising resul...
Combretastatin A4-Phosphate (CA4P) is a vascular disrupting agent revealing promising results in can...
Activation of one or both the Ras/MAPK and PI3K/Akt/mTOR signal transduction pathways are known to m...
The melanocortin-4 receptor (MC4R) is involved in several physiological processes, including body we...
Background: Data regarding antimicrobial pharmacokinetics (PK) in critically ill dogs are lacking an...
Cimicoxib (CX) is a novel imidazole derivative that is a cyclo-oxygenase (COX)-2 selective non-stero...
Canine hypercortisolism is most often caused by an ACTH-secreting pituitary adenoma (pituitary-depen...
Canine hypercortisolism is most often caused by an ACTH-secreting pituitary adenoma (pituitary-depen...
Background: Data regarding antimicrobial pharmacokinetics (PK) in critically ill dogs are lacking an...
Cimicoxib (CX) is a novel imidazole derivative that is a cyclo-oxygenase (COX)-2 selective non-stero...
BackgroundNonresectable mast cell tumors (MCT) in dogs remain a therapeutic challenge, and investiga...
Accumulation of lipofuscin bisretinoids in the retina contributes to pathogenesis of macular degener...
Due to the character of the original source materials and the nature of batch digitization, quality ...
Cimicoxib is a new coxib anti-inflammatory drug for use in the dog. To determine a preclinical dosag...
Combretastatin A4-Phosphate (CA4P) is a vascular disrupting agent revealing promising results in can...
<p>Combretastatin A4-Phosphate (CA4P) is a vascular disrupting agent revealing promising resul...
Combretastatin A4-Phosphate (CA4P) is a vascular disrupting agent revealing promising results in can...
Activation of one or both the Ras/MAPK and PI3K/Akt/mTOR signal transduction pathways are known to m...
The melanocortin-4 receptor (MC4R) is involved in several physiological processes, including body we...
Background: Data regarding antimicrobial pharmacokinetics (PK) in critically ill dogs are lacking an...
Cimicoxib (CX) is a novel imidazole derivative that is a cyclo-oxygenase (COX)-2 selective non-stero...
Canine hypercortisolism is most often caused by an ACTH-secreting pituitary adenoma (pituitary-depen...
Canine hypercortisolism is most often caused by an ACTH-secreting pituitary adenoma (pituitary-depen...
Background: Data regarding antimicrobial pharmacokinetics (PK) in critically ill dogs are lacking an...
Cimicoxib (CX) is a novel imidazole derivative that is a cyclo-oxygenase (COX)-2 selective non-stero...
BackgroundNonresectable mast cell tumors (MCT) in dogs remain a therapeutic challenge, and investiga...
Accumulation of lipofuscin bisretinoids in the retina contributes to pathogenesis of macular degener...
Due to the character of the original source materials and the nature of batch digitization, quality ...
Cimicoxib is a new coxib anti-inflammatory drug for use in the dog. To determine a preclinical dosag...